Skip to content

Health— page 18

health

Novo, Orbis sign up to $1.4 billion deal to develop oral drugs

By Siddhi Mahatole Sept 17 (Reuters) – Orbis Medicines said on Thursday it had signed a drug discovery and licensing agreement worth up to $1.4 billion with Novo Nordisk to develop oral therapies for cardiometabolic diseases, traditionally treated with injectable drugs. Here are the details: • The d

· SRN Health
Novo, Orbis sign up to $1.4 billion deal to develop oral drugs
health

Drugmakers prepare for next phase of space pharmaceuticals as ISS retirement nears

By Akash Sriram and Mariam Sunny Sept 17 (Reuters) – As the International Space Station nears the end of its operational life, drugmakers are laying the groundwork for commercial pharmaceutical research and manufacturing in low Earth orbit, while working with regulators to establish rules for produc

· SRN Health
Drugmakers prepare for next phase of space pharmaceuticals as ISS retirement nears
health

Advent to invest $328.5 million in India’s Yatharth Hospital for 24.9% stake

Sept 17 (Reuters) – U.S.-based private equity firm Advent International said on Thursday it will invest 31.5 billion rupees ($328.53 million) in Yatharth Hospital for a 24.9% stake, sending shares of the Indian hospital operator to a record high. Shares rose as much as 8.6% to an all-time high of 1,

· SRN Health
health

Healthcare firm Ramsay Generale de Sante sees 2027 revenue rising by up to 3%

Sept 17 (Reuters) – French healthcare provider Ramsay Generale de Sante expects its revenue to grow by 2% to 3% in 2027, with a stable core profit margin compared to 2026, it said ahead of its capital markets day on Thursday. The company expects its gross capital expenditure to average about 4% of r

· SRN Health
health

Fiji declares HIV a national crisis as diagnoses surge

WELLINGTON, Sept 17 (Reuters) – Fiji has declared HIV a national crisis after new diagnoses climbed 27% last year, intensifying concern that an epidemic once concentrated among people who inject drugs is spreading more widely through the Pacific island nation. The government said in a statement post

· SRN Health
Fiji declares HIV a national crisis as diagnoses surge
health

Novartis halts ALS drug development after mid-stage trial failure

By Sriparna Roy Sept 16 (Reuters) – Novartis has halted development of an experimental drug for amyotrophic lateral sclerosis after it failed to meet goals in a mid-stage study, marking the latest disappointment for the Swiss drugmaker this year. This follows an earlier setback for a closely watched

· SRN Health
Novartis halts ALS drug development after mid-stage trial failure
health

Scientists transplant lab-grown human brain tissue into mice

By Will Dunham WASHINGTON, Sept 16 (Reuters) – Scientists have transplanted laboratory-grown human brain tissue into bioengineered mice in what they call an important advance for studying human brain development that may speed research into the causes and mechanisms of devastating disorders such as

· SRN Health
Scientists transplant lab-grown human brain tissue into mice
health

Ebola response making progress in Congo, but outbreak ‘far from over,’ WHO says

By Siddhi Mahatole Sept 16 (Reuters) – The World Health Organization said on Wednesday there were encouraging signs measures to contain an Ebola epidemic in Democratic Republic of Congo were gaining ground, though it warned the outbreak was “far from over.” Transmission was declining in the most aff

· SRN Health
Ebola response making progress in Congo, but outbreak ‘far from over,’ WHO says
health

Novo partners with Anthropic to speed up drug development with Claude

Sept 16 (Reuters) – Novo Nordisk has partnered with Anthropic to use the AI giant’s Claude models to speed up discovery and development of new medicines, the companies said on Wednesday. Here are more details: • The Danish drugmaker will initially test Anthropic models and Claude Science in its rese

· SRN Health
Novo partners with Anthropic to speed up drug development with Claude
health

Sling Therapeutics raises $123 million to advance thyroid eye disease drug

By Kunal Das and Siddhi Mahatole Sept 16 (Reuters) – Drug developer Sling Therapeutics said on Wednesday it had raised $123 million to advance a late-stage trial of its experimental oral drug to treat thyroid eye disease. The disease causes inflammation and swelling around the eyes, which can lead t

· SRN Health
Sling Therapeutics raises $123 million to advance thyroid eye disease drug
health

Health Rounds: New dye for MRI exams detects lung cancer earlier

By Nancy Lapid Sept 15 (Reuters) – Hello Health Rounds readers! Today we highlight a potentially game-changing experimental contrast agent for MRI exams that may enable detection of lung cancer when tumors are small and more treatment options are available. We also report on a Johnson & Johnson anti

· SRN Health
Health Rounds: New dye for MRI exams detects lung cancer earlier
health

Centenarians living in Japan exceed 100,000 for the first time

TOKYO (AP) — The number of people aged 100 or older in Japan surpassed a record 100,000 this year, the latest government figures show, underscoring the country’s rapidly aging and declining population. The Health and Welfare Ministry statistics released Tuesday show Japan now has 107,677 centenarian

· SRN Health
Centenarians living in Japan exceed 100,000 for the first time
health

A childhood rite moves indoors as kindergartners learn to ride bikes in school gyms

For generations, kids have learned how to ride a bike — a quintessential childhood milestone — in driveways, on sidewalks and in neighborhood streets. Now, they’re learning in school gyms and playgrounds. On a recent September day, kindergarteners at Terra Vista Elementary School in Rancho Cucamonga

· SRN Health
A childhood rite moves indoors as kindergartners learn to ride bikes in school gyms
health

Aid cuts hit disease prevention harder than treatment, Global Fund chief says

By Jennifer Rigby LONDON, Sept 16 (Reuters) – Efforts to prevent people from getting AIDS, malaria and tuberculosis were hit harder by global aid cuts last year than services to treat existing patients, according to the head of a global partnership to fight the three killer diseases. That saved live

· SRN Health
health

A fourth measles death is reported in Pennsylvania

NEW YORK (AP) — Pennsylvania officials have reported a fourth measles-associated death. The latest death involved an 18-year-old resident of Mifflin County, in the center of the state, the county coroner’s office said in a Facebook post. The cause was acute disseminated encephalomyelitis, a rare and

· SRN Health
A fourth measles death is reported in Pennsylvania
health

Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean

Sept 15 (Reuters) – U.S. drugmaker Gilead Sciences said on Tuesday it had reached an agreement with the Pan American Health Organization to widen access to its HIV prevention drug across Latin America and the Caribbean, as the regions seek to curb new infections. Under the new agreement, countries t

· SRN Health
Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean
health

Novo CEO urges staff to embrace more customer-focused culture

By Jacob Gronholt-Pedersen COPENHAGEN, Sept 15 (Reuters) – Novo Nordisk’s CEO Mike Doustdar on Tuesday urged employees to be more customer-focused, as the Wegovy maker seeks to regain ground in the fast-growing obesity drug market. The push comes as investors question whether Doustdar can restore No

· SRN Health
Novo CEO urges staff to embrace more customer-focused culture
health

Legend Biotech taps Novartis veteran Zhang as CEO

By Siddhi Mahatole Sept 15 (Reuters) – Legend Biotech on Tuesday appointed longtime Novartis executive Ingrid Zhang as its CEO, effective immediately, banking on an industry veteran to steer its expansion beyond blockbuster cancer therapy Carvykti. Zhang most recently served as Novartis’ internation

· SRN Health
health

Testosterone scripts for women rise, along with denials and delays

By Mrinalika Roy Sept 15 (Reuters) – Women increasingly turning to testosterone therapy to manage menopause symptoms are running into unexpected prescription delays and denials at pharmacies, according to interviews with more than half a dozen doctors, nurses and patients. There is no U.S.-approved

· SRN Health
Testosterone scripts for women rise, along with denials and delays
health

GSK strikes up to $750 million deal for cancer-targeting drug

Sept 15 (Reuters) – GSK said on Tuesday it had agreed a deal worth up to $750 million to buy a trispecific T cell-engager (TCE), a drug designed to help T-cells target cancer, from China-based biotechnology firm Chimagen Biosciences. • A trispecific T cell-engager is an engineered protein that bring

· SRN Health